Inspirisys Solutions Ratios

Inspirisys Solutions Ltd Ratios

The Inspirisys Solutions Ltd Ratios page provides a complete fundamental analysis of Inspirisys Solutions Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Inspirisys Solutions Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Inspirisys Solutions Ltd (NSE: INSPIRISYS, BSE: 532774) is currently trading at ₹86.57, with a market capitalization of ₹3.49B. As a major player in the Technology services sector and Information technology services industry, Inspirisys Solutions Ltd remains a key stock for fundamental analysis using Inspirisys Solutions Ltd Ratios.

Inspirisys Solutions Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Inspirisys Solutions Ltd P/E ratio currently stands at 9.36, making it one of the most tracked metrics in Inspirisys Solutions Ltd Ratios.

Historically, the Inspirisys Solutions Ltd P/E ratio has shown strong fluctuations:

• 2024: 9.36
• 2023: 113.66
• 2022: 0
• 2021: 0
• 2020: 0

The decline in Inspirisys Solutions Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Inspirisys Solutions Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 5.08.

Historical P/B trend:

• 2024: 5.08
• 2023: 14.20
• 2022: 0
• 2021: 293.87

Inspirisys Solutions Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Inspirisys Solutions Ltd P/S ratio currently stands at 0.77, an important part of Inspirisys Solutions Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 0.77
• 2023: 0.85
• 2022: 0.47
• 2021: 0.68

A stable or declining Inspirisys Solutions Ltd P/S ratio indicates cautious market sentiment.

Inspirisys Solutions Ltd Price to Cash Flow Ratio (P/CF)

The Inspirisys Solutions Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 9.38.

Historical Inspirisys Solutions Ltd Price to Cash Flow Ratio:

• 2024: 9.38
• 2023: 21.05
• 2022: 15.51
• 2021: 0
• 2020: 2.80

The declining Inspirisys Solutions Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Inspirisys Solutions Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Inspirisys Solutions Ltd EV currently stands at ₹3.03B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 3.03B
• 2023: 4.4B
• 2022: 2.48B
• 2021: 3.19B

Inspirisys Solutions Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Inspirisys Solutions Ltd EV/EBITDA ratio is currently 9.01, a key metric in Inspirisys Solutions Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 9.01
• 2023: 12.77
• 2022: 8.30
• 2021: 0

Stable Inspirisys Solutions Ltd EV/EBITDA indicates balanced valuation.

Inspirisys Solutions Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Inspirisys Solutions Ltd D/E ratio is currently 1.44, reflecting leverage and financial stability.

Historical D/E:

• 2024: 1.44
• 2023: 2.83
• 2022: 0
• 2021: 138.13

Higher D/E ratio indicates rising financial risk.

Return on Equity (ROE %)

The Inspirisys Solutions Ltd ROE currently stands at 60.19%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 60.19
• 2023: 156.41
• 2022: 0
• 2021: -166.02

Inspirisys Solutions Ltd demonstrates strong profitability and efficient capital utilization.

Inspirisys Solutions Ltd Ratios Analysis Summary

The Inspirisys Solutions Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Inspirisys Solutions Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Inspirisys Solutions Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.